Novel multistage model enhances OCT GA segmentation
EMA application filed by Bayer to expand aflibercept 8mg indication to include retinal vein occlusion
Relationship between fasting C-peptide and diabetic retinopathy in patients with type 2 diabetes mellitus
FDA accepts biologics license application from Outlook Therapeutics for ONS-5010 for the treatment of wet AMD
